Market Cap 866.23M
Revenue (ttm) 55.25M
Net Income (ttm) -334.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -605.12%
Debt to Equity Ratio -0.51
Volume 1,044,700
Avg Vol 1,147,370
Day's Range N/A - N/A
Shares Out 70.94M
Stochastic %K 72%
Beta 0.43
Analysts Strong Sell
Price Target $21.38

Company Profile

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heart...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 742 8466
Address:
100 Campus Drive, Suite 102, Florham Park, United States
OnlyFibs
OnlyFibs Oct. 5 at 12:36 AM
$PHAT - Phantom Pharm - Bullish -inside month -inside week - consolidation on all time frames letting ma bands catch up on 8hr look for this to claim $12.67 and run #hovdid
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 7:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $12.21 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.62- $4.43 Scale out: $5.64-$7.25 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 1:46 AM
$PHAT: Unusual Options Activity Alerted CALL flow observed 100x contracts at Strike price of $7.5 Exp on 02/20/2026 with Premium of $52K and showing NEUTRAL Sentiment
1 · Reply
Dr_Stoxx
Dr_Stoxx Oct. 3 at 7:28 PM
Time for a big $PHAT update: still no real movement yet...but the lows are getting higher.
0 · Reply
HotStockScreener
HotStockScreener Oct. 3 at 5:32 PM
$PHAT Next leg up in preparation 🚀
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 2 at 5:02 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $12.29 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.56- $4.35 Scale out: $5.53-$7.11 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Walleyeslayer
Walleyeslayer Oct. 1 at 9:36 PM
$PHAT Two days in a row volume up about 80% over the average.....
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 1 at 8:59 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $11.77 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.84- $4.69 Scale out: $5.97-$7.67 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Walleyeslayer
Walleyeslayer Oct. 1 at 2:02 PM
$PHAT Volume jump yesterday. Holding strong. Sure smells like we are getting close to another move north. Long and strong.
0 · Reply
Snatchman
Snatchman Oct. 1 at 1:51 PM
0 · Reply
Latest News on PHAT
Frazier Life Sciences Appoints Aditya Kohli to Partner

Apr 17, 2025, 8:00 AM EDT - 6 months ago

Frazier Life Sciences Appoints Aditya Kohli to Partner

HLVX


Phathom Pharmaceuticals Announces Leadership Succession

Apr 1, 2025, 8:00 AM EDT - 6 months ago

Phathom Pharmaceuticals Announces Leadership Succession


Phathom Pharma Is A Buy Before July PDUFA

Jan 1, 2024, 6:41 AM EST - 1 year ago

Phathom Pharma Is A Buy Before July PDUFA


Following Up On Phathom Pharmaceuticals

Oct 5, 2023, 12:43 PM EDT - 2 years ago

Following Up On Phathom Pharmaceuticals


OnlyFibs
OnlyFibs Oct. 5 at 12:36 AM
$PHAT - Phantom Pharm - Bullish -inside month -inside week - consolidation on all time frames letting ma bands catch up on 8hr look for this to claim $12.67 and run #hovdid
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 7:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $12.21 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.62- $4.43 Scale out: $5.64-$7.25 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 1:46 AM
$PHAT: Unusual Options Activity Alerted CALL flow observed 100x contracts at Strike price of $7.5 Exp on 02/20/2026 with Premium of $52K and showing NEUTRAL Sentiment
1 · Reply
Dr_Stoxx
Dr_Stoxx Oct. 3 at 7:28 PM
Time for a big $PHAT update: still no real movement yet...but the lows are getting higher.
0 · Reply
HotStockScreener
HotStockScreener Oct. 3 at 5:32 PM
$PHAT Next leg up in preparation 🚀
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 2 at 5:02 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $12.29 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.56- $4.35 Scale out: $5.53-$7.11 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Walleyeslayer
Walleyeslayer Oct. 1 at 9:36 PM
$PHAT Two days in a row volume up about 80% over the average.....
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 1 at 8:59 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $11.77 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.84- $4.69 Scale out: $5.97-$7.67 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Walleyeslayer
Walleyeslayer Oct. 1 at 2:02 PM
$PHAT Volume jump yesterday. Holding strong. Sure smells like we are getting close to another move north. Long and strong.
0 · Reply
Snatchman
Snatchman Oct. 1 at 1:51 PM
0 · Reply
highnihilism
highnihilism Oct. 1 at 9:15 AM
$API Agora Trade Count: 37 | Total $: 3.9 K | 0.95 × 90-Day Avg $: 4.1 K | Call $: 3.9 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ARHS Arhaus Trade Count: 15 | Total $: 11.3 K | 0.50 × 90-Day Avg $: 22.8 K | Call $: 3.9 K | Put $: 7.5 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PHAT Phathom Pharmaceuticals Trade Count: 14 | Total $: 6.4 K | 0.04 × 90-Day Avg $: 169.1 K | Call $: 3.9 K | Put $: 2.6 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ABVC Abvc Biopharma Trade Count: 6 | Total $: 3.8 K | 4.54 × 90-Day Avg $: 845 | Call $: 3.8 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
Morrito23
Morrito23 Sep. 30 at 7:47 PM
$PHAT Someone ATE those shares waiting at around the 11.95’s price. That was a huge block of shares traded.
0 · Reply
Dr_Stoxx
Dr_Stoxx Sep. 30 at 6:21 PM
$PHAT looks, well, phat.
2 · Reply
Snatchman
Snatchman Sep. 30 at 3:08 PM
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 1:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $11.52 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $3.59- $4.39 Scale out: $5.58-$7.18 Can Easily Capture: 60% ROI Blended DTE: 473 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Hendo111
Hendo111 Sep. 29 at 2:53 PM
$PHAT adding $CEIN
0 · Reply
Hernandrod12
Hernandrod12 Sep. 29 at 12:42 PM
0 · Reply
GluttonBoy
GluttonBoy Sep. 29 at 12:38 AM
$AMS Micro float making a big move up , Looks like it could run up 100% tomorrow - keep it on watch $QURE FDA Approval coming? Biotech gem 💎 $BRTX $5 target $PHAT Insiders own 60%+ looking for potential entries.
0 · Reply
LegendaryCharts
LegendaryCharts Sep. 29 at 12:08 AM
$PAVS Micro float making a big move up , Looks like it could run up 100% tomorrow - keep it on watch $EYEN UFD update? $BRTX Going to 5 soon $PHAT Insiders own 60%+
1 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 28 at 10:40 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PHAT Current Share Price: $11.78 Contracts: $PHAT January 15, 2027 $12 Calls Scale in: $4.05- $4.95 Scale out: $6.30-$8.10 Can Easily Capture: 60% ROI Blended DTE: 474 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Damian23
Damian23 Sep. 28 at 3:35 PM
$PHAT Market cap approx. $836 million, total debt $574 million, cash $150 million. Enterprise Value (EV) = 836 + 574 - 150 = $1,260 million. Revenue Q2 2025 $39.5 million, sequential growth 39%, strong momentum. 2025 revenue guidance $165M to $175M (midpoint $170M). Gross margin stable ~87%. Operating expenses expected to decline: Q3 < $60M, Q4 < $55M. Net loss Q2 2025 $75.8 million, improving from 2024. Cash burn rate (non-GAAP OpEx excluding non-cash) roughly $53M quarterly (averaging Q3/Q4 estimates and steady revenue/gross margins). Cash runway = $150M / $53M ≈ 2.8 quarters at current spending before cash depletion (excluding revenue cash inflows). Management targets profitability in 2026 with increased revenues and reduced costs. Break-even revenue calculation: Assuming 87% gross margin and $55M quarterly OpEx (non-GAAP), break-even top-line quarterly revenue approx = $55M / 0.87 ≈ $63 million.
1 · Reply
fgggggggg
fgggggggg Sep. 27 at 12:28 PM
$PHAT it is interesting that the CEOs Form 4 that was filed yesterday notes that his grant vested due to meeting the stock price hurdle. I like stock price being a motivation.
0 · Reply